Australia markets closed

Jack Nathan Medical Corp. (JNHMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.11990.0000 (0.00%)
At close: 02:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1199
Open0.1199
BidN/A x N/A
AskN/A x N/A
Day's range0.1199 - 0.1199
52-week range0.0350 - 0.2890
Volume5,000
Avg. volume11,417
Market cap7.674M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jack Nathan Health Announces Its Q2 Fiscal 2023 Financial Results

    TORONTO, September 29, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated annual financial results for the second quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

  • Business Wire

    Jack Nathan Health to Secure a Revolving Credit Facility

    TORONTO, September 27, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") and Wal-Mart Canada Corp. ("Walmart Canada") announce today that they have entered into a loan agreement (the "Loan Agreement") in order to establish a new revolving credit facility in an amount not to exceed CAD$2,000,000 (the "Loan") in favour of the Company maturing on a date that is the earlier of (i) the date upon which demand is made by Walmart Canada pursuant to

  • Business Wire

    Jack Nathan Health to Appoint New Chief Financial Officer

    TORONTO, September 20, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announces that David Berman stepped down from his position as Chief Financial Officer of the Company effective as September 19, 2022. "On behalf of myself and the board of directors, we want to thank David for his contributions to Jack Nathan Health. He has been a key contributor to our success to date, and we wish him the best in his future endeavors," said Dr. Glenn C